MLL
Magazine

Here you will find all MLL news as well as scientific contributions to leukemia diagnostics and research

Current articles

Prof. Dr. med. Dr. phil. Torsten Haferlach
from 18.08.2020
MLL News
15 Years of MLL Munich Leukemia Laboratory: an anniversary without celebrations

We opened the MLL on August 1, 2005. The number of samples at the MLL and the possibilities for diagnostic methods have developed in parallel with hematology in the last 15 years. Diagnostics with all its possibilities and needs is becoming more and more exciting for us. It is growing in importance for patients and attending physicians. This is true regarding the description of the disease and its risk profile during diagnosis, as well as to the analyses of the course of the disease, whose numbers have increased sharply, which contribute to therapy management. The total number of samples sent to the MLL in the last 15 years is now over 750,000.

Dr. rer. nat. Manja Meggendorfer, MBA
from 14.08.2020
MLL News
MLL Dx – the new website is live

The MLL Munich Leukemia Laboratory has been providing comprehensive diagnostics for leukemia and lymphoma patients in our health system for 15 years. Molecular genetics has been an increasingly important component. The demand for comprehensive diagnostics, including from neighboring countries, is rising. Why not also offer this service outside the German health system? The three managing directors asked this question before the idea of establishing MLL Dx – MLL diagnostics – took shape. MLL Dx was founded as an affiliate of MLL in 2018 and has been visible through its own web site since July 2020.

Dr. Wencke Walter
from 18.08.2020
Diagnostics
Diagnostic perspectives – WGS and WTS

The diagnosis and classification of hematological neoplasia is a complex process. Various diagnostic technologies (cytomorphology, histology, cytogenetics, immunophenotyping and molecular genetics) are needed to meet the clinical challenges for a rapid, accurate and therapeutically relevant diagnosis for each patient. Genetic testing in particular has changed considerably in recent years, making it a quick and comprehensive option for a variety of issues.

Prof. Dr. med. Dr. phil. Torsten Haferlach
from 08.06.2020
MLL News
Leukemia diagnostics during the pandemic

In the past few months, we have all been confronted with an entirely new situation. Our patients belong to the high-risk group by definition. Hospitals, outpatient clinics, and medical practices have had to be restructured and reorganize their priorities. Workflows had to be re-examined with regard to factual and time-related aspects with hygiene in mind. The goal has been to ensure continued care for patients, while at the same time protecting the employees trained for that very purpose.

Newsletter registration


Sign up for our MLL News and receive information on latest findings in leukemia diagnostics and research. Newsletter only available in German.
 
Sign up now